NCT02732275 2025-02-07DS-3201b in Participants With LymphomasDaiichi SankyoPhase 1 Active not recruiting100 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled